FDA approves Bristol Myers Squibb’s Opdivo for lung cancer

March 5, 2015 12:41 PM

4 0

FDA approves Bristol Myers Squibb’s Opdivo for lung cancer

U.S. regulators approved Bristol-Myers Squibb Co. ’s advanced lung cancer drug Opdivo, the latest of a string of events that has focused efforts on using the immune system to battle the disease.

The action by the U.S. Food and Drug Administration came three months ahead of the agency’s deadline for reviewing the drug and just two months after a clinical trial of Opdivo was stopped early because of a significant improvement in survival. Lung cancer is the leading cause of cancer death in the...

Read more

To category page

Loading...